APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceuticals and Excipients

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceuticals and Excipients Market Outlook and Growth Opportunities 2026

31 December 2025199 pages

Choose your research edition.

Industry ResearchPharmaceuticals and Excipients Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceuticals and Excipients Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharmaceuticals and Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceuticals and Excipients Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceuticals and Excipients Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pharmaceuticals and Excipients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceuticals and Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceuticals and Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceuticals and Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceuticals and Excipients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceuticals and Excipients market include Signet Chemical Corporation, Sigachi Industries, Shin-Etsu, Roquette, MEGGLE AG, Lubrizol, JRS Pharma, Evonik and ER-KANG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceuticals and Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceuticals and Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceuticals and Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceuticals and Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceuticals and Excipients Segment by Company

Signet Chemical Corporation

Sigachi Industries

Shin-Etsu

Roquette

MEGGLE AG

Lubrizol

JRS Pharma

Evonik

ER-KANG

Dow

BASF

Ashland

ABITEC Corp

Pharmaceuticals and Excipients Segment by Type

Starch

Mannitol

Triglycerides

Dextrose

Sorbitol

Sucrose

Others

Pharmaceuticals and Excipients Segment by Application

Parenteral Formulations

Topical Formulations

Oral Formulations

Other

Pharmaceuticals and Excipients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pharmaceuticals and Excipients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceuticals and Excipients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceuticals and Excipients significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceuticals and Excipients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceuticals and Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceuticals and Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceuticals and Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceuticals and Excipients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceuticals and Excipients industry.

Chapter 3: Detailed analysis of Pharmaceuticals and Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceuticals and Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceuticals and Excipients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceuticals and Excipients Industry Trends Table 2. Pharmaceuticals and Excipients Industry Drivers Table 3. Pharmaceuticals and Excipients Industry Opportunities and Challenges Table 4. Pharmaceuticals and Excipients Industry Restraints Table 5. Global Pharmaceuticals and Excipients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceuticals and Excipients Revenue Share by Company (2021-2026) Table 7. Global Pharmaceuticals and Excipients Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Pharmaceuticals and Excipients Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceuticals and Excipients Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Pharmaceuticals and Excipients Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceuticals and Excipients Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceuticals and Excipients Company, Product Type & Application Table 13. Global Pharmaceuticals and Excipients Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceuticals and Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Starch Table 18. Significant Companies of Mannitol Table 19. Significant Companies of Triglycerides Table 20. Significant Companies of Dextrose Table 21. Significant Companies of Sorbitol Table 22. Significant Companies of Sucrose Table 23. Significant Companies of Others Table 24. Global Pharmaceuticals and Excipients Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global Pharmaceuticals and Excipients Sales Volume by Type (2021-2026) & (Tons) Table 26. Global Pharmaceuticals and Excipients Sales Volume by Type (2027-2032) & (Tons) Table 27. Global Pharmaceuticals and Excipients Sales Volume Share by Type (2021-2026) Table 28. Global Pharmaceuticals and Excipients Sales Volume Share by Type (2027-2032) Table 29. Global Pharmaceuticals and Excipients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pharmaceuticals and Excipients Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Pharmaceuticals and Excipients Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Pharmaceuticals and Excipients Sales Value Share by Type (2021-2026) Table 33. Global Pharmaceuticals and Excipients Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Parenteral Formulations Table 35. Significant Companies of Topical Formulations Table 36. Significant Companies of Oral Formulations Table 37. Significant Companies of Other Table 38. Global Pharmaceuticals and Excipients Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 39. Global Pharmaceuticals and Excipients Sales Volume by Application (2021-2026) & (Tons) Table 40. Global Pharmaceuticals and Excipients Sales Volume by Application (2027-2032) & (Tons) Table 41. Global Pharmaceuticals and Excipients Sales Volume Share by Application (2021-2026) Table 42. Global Pharmaceuticals and Excipients Sales Volume Share by Application (2027-2032) Table 43. Global Pharmaceuticals and Excipients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Pharmaceuticals and Excipients Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Pharmaceuticals and Excipients Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Pharmaceuticals and Excipients Sales Value Share by Application (2021-2026) Table 47. Global Pharmaceuticals and Excipients Sales Value Share by Application (2027-2032) Table 48. Global Pharmaceuticals and Excipients Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 49. Global Pharmaceuticals and Excipients Sales by Region (2021-2026) & (Tons) Table 50. Global Pharmaceuticals and Excipients Sales Market Share by Region (2021-2026) Table 51. Global Pharmaceuticals and Excipients Sales by Region (2027-2032) & (Tons) Table 52. Global Pharmaceuticals and Excipients Sales Market Share by Region (2027-2032) Table 53. Global Pharmaceuticals and Excipients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Pharmaceuticals and Excipients Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Pharmaceuticals and Excipients Sales Value Share by Region (2021-2026) Table 56. Global Pharmaceuticals and Excipients Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Pharmaceuticals and Excipients Sales Value Share by Region (2027-2032) Table 58. Global Pharmaceuticals and Excipients Market Average Price (US$/Ton) by Region (2021-2026) Table 59. Global Pharmaceuticals and Excipients Market Average Price (US$/Ton) by Region (2027-2032) Table 60. Global Pharmaceuticals and Excipients Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 61. Global Pharmaceuticals and Excipients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Pharmaceuticals and Excipients Sales by Country (2021-2026) & (Tons) Table 63. Global Pharmaceuticals and Excipients Sales Market Share by Country (2021-2026) Table 64. Global Pharmaceuticals and Excipients Sales by Country (2027-2032) & (Tons) Table 65. Global Pharmaceuticals and Excipients Sales Market Share by Country (2027-2032) Table 66. Global Pharmaceuticals and Excipients Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Pharmaceuticals and Excipients Sales Value Market Share by Country (2021-2026) Table 68. Global Pharmaceuticals and Excipients Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Pharmaceuticals and Excipients Sales Value Market Share by Country (2027-2032) Table 70. Signet Chemical Corporation Company Information Table 71. Signet Chemical Corporation Business Overview Table 72. Signet Chemical Corporation Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Signet Chemical Corporation Pharmaceuticals and Excipients Product Portfolio Table 74. Signet Chemical Corporation Recent Development Table 75. Sigachi Industries Company Information Table 76. Sigachi Industries Business Overview Table 77. Sigachi Industries Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Sigachi Industries Pharmaceuticals and Excipients Product Portfolio Table 79. Sigachi Industries Recent Development Table 80. Shin-Etsu Company Information Table 81. Shin-Etsu Business Overview Table 82. Shin-Etsu Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Shin-Etsu Pharmaceuticals and Excipients Product Portfolio Table 84. Shin-Etsu Recent Development Table 85. Roquette Company Information Table 86. Roquette Business Overview Table 87. Roquette Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Roquette Pharmaceuticals and Excipients Product Portfolio Table 89. Roquette Recent Development Table 90. MEGGLE AG Company Information Table 91. MEGGLE AG Business Overview Table 92. MEGGLE AG Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. MEGGLE AG Pharmaceuticals and Excipients Product Portfolio Table 94. MEGGLE AG Recent Development Table 95. Lubrizol Company Information Table 96. Lubrizol Business Overview Table 97. Lubrizol Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Lubrizol Pharmaceuticals and Excipients Product Portfolio Table 99. Lubrizol Recent Development Table 100. JRS Pharma Company Information Table 101. JRS Pharma Business Overview Table 102. JRS Pharma Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. JRS Pharma Pharmaceuticals and Excipients Product Portfolio Table 104. JRS Pharma Recent Development Table 105. Evonik Company Information Table 106. Evonik Business Overview Table 107. Evonik Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Evonik Pharmaceuticals and Excipients Product Portfolio Table 109. Evonik Recent Development Table 110. ER-KANG Company Information Table 111. ER-KANG Business Overview Table 112. ER-KANG Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. ER-KANG Pharmaceuticals and Excipients Product Portfolio Table 114. ER-KANG Recent Development Table 115. Dow Company Information Table 116. Dow Business Overview Table 117. Dow Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Dow Pharmaceuticals and Excipients Product Portfolio Table 119. Dow Recent Development Table 120. BASF Company Information Table 121. BASF Business Overview Table 122. BASF Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. BASF Pharmaceuticals and Excipients Product Portfolio Table 124. BASF Recent Development Table 125. Ashland Company Information Table 126. Ashland Business Overview Table 127. Ashland Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Ashland Pharmaceuticals and Excipients Product Portfolio Table 129. Ashland Recent Development Table 130. ABITEC Corp Company Information Table 131. ABITEC Corp Business Overview Table 132. ABITEC Corp Pharmaceuticals and Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. ABITEC Corp Pharmaceuticals and Excipients Product Portfolio Table 134. ABITEC Corp Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Pharmaceuticals and Excipients Distributors List Table 138. Pharmaceuticals and Excipients Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Pharmaceuticals and Excipients Product Image Figure 2. Global Pharmaceuticals and Excipients Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceuticals and Excipients Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceuticals and Excipients Sales (2021-2032) & (Tons) Figure 5. Global Pharmaceuticals and Excipients Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Pharmaceuticals and Excipients Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Starch Image Figure 10. Mannitol Image Figure 11. Triglycerides Image Figure 12. Dextrose Image Figure 13. Sorbitol Image Figure 14. Sucrose Image Figure 15. Others Image Figure 16. Global Pharmaceuticals and Excipients Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 17. Global Pharmaceuticals and Excipients Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceuticals and Excipients Sales Volume Share by Type (2021-2032) Figure 19. Global Pharmaceuticals and Excipients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharmaceuticals and Excipients Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Pharmaceuticals and Excipients Sales Value Share by Type (2021-2032) Figure 22. Parenteral Formulations Image Figure 23. Topical Formulations Image Figure 24. Oral Formulations Image Figure 25. Other Image Figure 26. Global Pharmaceuticals and Excipients Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 27. Global Pharmaceuticals and Excipients Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Pharmaceuticals and Excipients Sales Volume Share by Application (2021-2032) Figure 29. Global Pharmaceuticals and Excipients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Pharmaceuticals and Excipients Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Pharmaceuticals and Excipients Sales Value Share by Application (2021-2032) Figure 32. Global Pharmaceuticals and Excipients Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 33. Global Pharmaceuticals and Excipients Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Pharmaceuticals and Excipients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Pharmaceuticals and Excipients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Pharmaceuticals and Excipients Sales Value (2021-2032) & (US$ Million) Figure 37. North America Pharmaceuticals and Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Pharmaceuticals and Excipients Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Pharmaceuticals and Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Pharmaceuticals and Excipients Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Pharmaceuticals and Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Pharmaceuticals and Excipients Sales Value (2021-2032) & (US$ Million) Figure 43. South America Pharmaceuticals and Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Pharmaceuticals and Excipients Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Pharmaceuticals and Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Pharmaceuticals and Excipients Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Pharmaceuticals and Excipients Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Starch
  • Mannitol
  • Triglycerides
  • Dextrose
  • Sorbitol
  • Sucrose
  • Others
Applications
  • Parenteral Formulations
  • Topical Formulations
  • Oral Formulations
  • Other
Companies covered
  • Signet Chemical Corporation
  • Sigachi Industries
  • Shin-Etsu
  • Roquette
  • MEGGLE AG
  • Lubrizol
  • JRS Pharma
  • Evonik
  • ER-KANG
  • Dow
  • BASF
  • Ashland
  • ABITEC Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceuticals and Excipients Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceuticals and Excipients Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceuticals and Excipients Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceuticals and Excipients Market Dynamics
  1. 2.1 Pharmaceuticals and Excipients Industry Trends
  2. 2.2 Pharmaceuticals and Excipients Industry Drivers
  3. 2.3 Pharmaceuticals and Excipients Industry Opportunities and Challenges
  4. 2.4 Pharmaceuticals and Excipients Industry Restraints
3 Pharmaceuticals and Excipients Market by Company
  1. 3.1 Global Pharmaceuticals and Excipients Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceuticals and Excipients Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceuticals and Excipients Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceuticals and Excipients Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceuticals and Excipients Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceuticals and Excipients Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceuticals and Excipients Company Product Type and Application
  8. 3.8 Global Pharmaceuticals and Excipients Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceuticals and Excipients Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceuticals and Excipients Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceuticals and Excipients Market by Type
  1. 4.1 Pharmaceuticals and Excipients Type Introduction
  2. 4.1.1 Starch
  3. 4.1.2 Mannitol
  4. 4.1.3 Triglycerides
  5. 4.1.4 Dextrose
  6. 4.1.5 Sorbitol
  7. 4.1.6 Sucrose
  8. 4.1.7 Others
  9. 4.2 Global Pharmaceuticals and Excipients Sales Volume by Type
  10. 4.2.1 Global Pharmaceuticals and Excipients Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Pharmaceuticals and Excipients Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Pharmaceuticals and Excipients Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Pharmaceuticals and Excipients Sales Value by Type
  14. 4.3.1 Global Pharmaceuticals and Excipients Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Pharmaceuticals and Excipients Sales Value by Type (2021-2032)
  16. 4.3.3 Global Pharmaceuticals and Excipients Sales Value Share by Type (2021-2032)
5 Pharmaceuticals and Excipients Market by Application
  1. 5.1 Pharmaceuticals and Excipients Application Introduction
  2. 5.1.1 Parenteral Formulations
  3. 5.1.2 Topical Formulations
  4. 5.1.3 Oral Formulations
  5. 5.1.4 Other
  6. 5.2 Global Pharmaceuticals and Excipients Sales Volume by Application
  7. 5.2.1 Global Pharmaceuticals and Excipients Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceuticals and Excipients Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pharmaceuticals and Excipients Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pharmaceuticals and Excipients Sales Value by Application
  11. 5.3.1 Global Pharmaceuticals and Excipients Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pharmaceuticals and Excipients Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pharmaceuticals and Excipients Sales Value Share by Application (2021-2032)
6 Pharmaceuticals and Excipients Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceuticals and Excipients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceuticals and Excipients Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceuticals and Excipients Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceuticals and Excipients Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceuticals and Excipients Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceuticals and Excipients Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceuticals and Excipients Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceuticals and Excipients Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceuticals and Excipients Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceuticals and Excipients Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceuticals and Excipients Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceuticals and Excipients Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceuticals and Excipients Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceuticals and Excipients Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceuticals and Excipients Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceuticals and Excipients Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceuticals and Excipients Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceuticals and Excipients Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceuticals and Excipients Sales Value Share by Country, 2025 VS 2032
7 Pharmaceuticals and Excipients Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceuticals and Excipients Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceuticals and Excipients Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceuticals and Excipients Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceuticals and Excipients Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceuticals and Excipients Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceuticals and Excipients Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceuticals and Excipients Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceuticals and Excipients Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceuticals and Excipients Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceuticals and Excipients Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceuticals and Excipients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Signet Chemical Corporation
  2. 8.1.1 Signet Chemical Corporation Company Information
  3. 8.1.2 Signet Chemical Corporation Business Overview
  4. 8.1.3 Signet Chemical Corporation Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Signet Chemical Corporation Pharmaceuticals and Excipients Product Portfolio
  6. 8.1.5 Signet Chemical Corporation Recent Developments
  7. 8.2 Sigachi Industries
  8. 8.2.1 Sigachi Industries Company Information
  9. 8.2.2 Sigachi Industries Business Overview
  10. 8.2.3 Sigachi Industries Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sigachi Industries Pharmaceuticals and Excipients Product Portfolio
  12. 8.2.5 Sigachi Industries Recent Developments
  13. 8.3 Shin-Etsu
  14. 8.3.1 Shin-Etsu Company Information
  15. 8.3.2 Shin-Etsu Business Overview
  16. 8.3.3 Shin-Etsu Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shin-Etsu Pharmaceuticals and Excipients Product Portfolio
  18. 8.3.5 Shin-Etsu Recent Developments
  19. 8.4 Roquette
  20. 8.4.1 Roquette Company Information
  21. 8.4.2 Roquette Business Overview
  22. 8.4.3 Roquette Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roquette Pharmaceuticals and Excipients Product Portfolio
  24. 8.4.5 Roquette Recent Developments
  25. 8.5 MEGGLE AG
  26. 8.5.1 MEGGLE AG Company Information
  27. 8.5.2 MEGGLE AG Business Overview
  28. 8.5.3 MEGGLE AG Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MEGGLE AG Pharmaceuticals and Excipients Product Portfolio
  30. 8.5.5 MEGGLE AG Recent Developments
  31. 8.6 Lubrizol
  32. 8.6.1 Lubrizol Company Information
  33. 8.6.2 Lubrizol Business Overview
  34. 8.6.3 Lubrizol Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lubrizol Pharmaceuticals and Excipients Product Portfolio
  36. 8.6.5 Lubrizol Recent Developments
  37. 8.7 JRS Pharma
  38. 8.7.1 JRS Pharma Company Information
  39. 8.7.2 JRS Pharma Business Overview
  40. 8.7.3 JRS Pharma Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 JRS Pharma Pharmaceuticals and Excipients Product Portfolio
  42. 8.7.5 JRS Pharma Recent Developments
  43. 8.8 Evonik
  44. 8.8.1 Evonik Company Information
  45. 8.8.2 Evonik Business Overview
  46. 8.8.3 Evonik Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Evonik Pharmaceuticals and Excipients Product Portfolio
  48. 8.8.5 Evonik Recent Developments
  49. 8.9 ER-KANG
  50. 8.9.1 ER-KANG Company Information
  51. 8.9.2 ER-KANG Business Overview
  52. 8.9.3 ER-KANG Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ER-KANG Pharmaceuticals and Excipients Product Portfolio
  54. 8.9.5 ER-KANG Recent Developments
  55. 8.10 Dow
  56. 8.10.1 Dow Company Information
  57. 8.10.2 Dow Business Overview
  58. 8.10.3 Dow Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Dow Pharmaceuticals and Excipients Product Portfolio
  60. 8.10.5 Dow Recent Developments
  61. 8.11 BASF
  62. 8.11.1 BASF Company Information
  63. 8.11.2 BASF Business Overview
  64. 8.11.3 BASF Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 BASF Pharmaceuticals and Excipients Product Portfolio
  66. 8.11.5 BASF Recent Developments
  67. 8.12 Ashland
  68. 8.12.1 Ashland Company Information
  69. 8.12.2 Ashland Business Overview
  70. 8.12.3 Ashland Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ashland Pharmaceuticals and Excipients Product Portfolio
  72. 8.12.5 Ashland Recent Developments
  73. 8.13 ABITEC Corp
  74. 8.13.1 ABITEC Corp Company Information
  75. 8.13.2 ABITEC Corp Business Overview
  76. 8.13.3 ABITEC Corp Pharmaceuticals and Excipients Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ABITEC Corp Pharmaceuticals and Excipients Product Portfolio
  78. 8.13.5 ABITEC Corp Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceuticals and Excipients Value Chain Analysis
  2. 9.1.1 Pharmaceuticals and Excipients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceuticals and Excipients Sales Mode & Process
  6. 9.2 Pharmaceuticals and Excipients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceuticals and Excipients Distributors
  9. 9.2.3 Pharmaceuticals and Excipients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst